·07/05/10 Midlife Respiratory Function Related to White Matter Lesions and Lacunar Infarcts in Late Life
·07/05/10 Long-Term Risk Factors for Stroke
·07/05/10 Familial Risk of Ischemic and Hemorrhagic Stroke
·07/05/10 Stable Stroke Incidence Rates but Improved Case-Fatality in Dijon, France, From 1985 to 2004
·07/05/10 Adrenoceptor Polymorphisms and the Risk of Cardiac Injury and Dysfunction After Subarachnoid Hemorrhage
·07/05/10 Polymorphisms in the Advanced Glycosylation End Product–Specific Receptor Gene and Risk of Incident Myocardial Infarction or Ischemic Stroke
·07/05/10 Cytokine Polymorphisms Associated With Carotid Intima-Media Thickness in Stroke Patients
·07/05/10 Genetic Analysis of Familial Connective Tissue Alterations Associated With Cervical Artery Dissections Suggests Locus Heterogeneity
·07/05/10 Novel Genomic Loci Influencing Plasma Homocysteine Levels
·07/05/10 Is the ABCD Score Useful for Risk Stratification of Patients With Acute Transient Ischemic Attack
·07/05/10 Left Ventricular Systolic Dysfunction and the Risk of Ischemic Stroke in a Multiethnic Population
·07/05/10 C-Reactive Protein as a Predictor of Incident Ischemic Stroke Among Patients With Preexisting Cardiovascular Disease
·07/05/10 Cyclooxygenase-2 Selective Nonsteroidal Anti-Inflammatory Drugs and the Risk of Ischemic Stroke
·07/05/10 Impaired Inhibitory Effect of Interleukin-10 on the Balance Between Matrix Metalloproteinase-9 and Its Inhibitor in Mononuclear Cells From Hyperhomocysteinemic Subjects
·07/05/10 Previous Use of Aspirin and Baseline Stroke Severity
·07/05/10 Local Relationships Between Restricted Water Diffusion and Oxygen Consumption in the Ischemic Human Brain
·07/05/10 Intrinsic Activated Microglia Map to the Peri-infarct Zone in the Subacute Phase of Ischemic Stroke
·07/05/10 Cerebral Vasodilatation to Exogenous NO Is a Measure of Fitness for Life at Altitude
·07/05/10 White Matter Alterations in Cerebral Amyloid Angiopathy Measured by Diffusion Tensor Imaging
·07/05/10 Brain Gray Matter Changes in Migraine Patients With T2-Visible Lesions
·07/05/10 Identification of Penumbra and Infarct in Acute Ischemic Stroke Using Computed Tomography Perfusion–Derived Blood Flow and Blood Volume Measurements
·07/05/10 Blood Oxygen Level–Dependent MRI Allows Metabolic Description of Tissue at Risk in Acute Stroke Patients
·07/05/10 Effect of Nonoptimal Imaging on the Relationship Between the Measured Degree of Symptomatic Carotid Stenosis and Risk of Ischemic Stroke
·07/05/10 Efficacy and Safety of Endovascular Cooling After Cardiac Arrest
·07/05/10 Hemostatic Activation and Outcome After Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke
·07/05/10 Intravenous Versus Combined (Intravenous and Intra-Arterial) Thrombolysis in Acute Ischemic Stroke
·07/05/10 Alteplase at 0.6 mg/kg for Acute Ischemic Stroke Within 3 Hours of Onset
·07/05/10 Intravenous Administration of Acetylsalicylic Acid During Endovascular Treatment of Cerebral Aneurysms Reduces the Rate of Thromboembolic Events
·07/05/10 Comparison of Tissue Plasminogen Activator Administration Management Between Telestroke Network Hospitals and Academic Stroke Centers
·07/05/10 Large Subcortical Infarcts
·07/05/10 Retinal Arteriolar Emboli and Long-Term Mortality
·07/05/10 Acute Ischemic Stroke Care and Outcome in Centers Participating in the Polish National Stroke Prevention and Treatment Registry
·07/05/10 Quality of Hospital and Outpatient Care After Stroke or Transient Ischemic Attack
·07/05/10 Hypertrophy of Cerebral Arterioles in Mice Deficient in Expression of the Gene for CuZn Superoxide Dismutase
·07/05/10 In Vivo X-Ray Angiography in the Mouse Brain Using Synchrotron Radiation

1 [2] [下一页] [尾页]